Quantcast

Latest Uterine fibroids Stories

2011-05-19 15:36:00

NEW YORK, May 19, 2011 /PRNewswire/ -- EverydayHealth.com, a leading provider of online health solutions, is encouraging women to take charge of their health. During the month of May, Women's Health Awareness Month, the website is reporting on women's health innovations and promoting attendance for da Vinci Women's Health "Women'sWorks: Tools For a Healthier You" - free, doctor-led health education programs at hospitals across the country coordinated in support of National Women's Health...

2011-05-04 07:02:00

BEDFORD, Mass., May 4, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, is featuring new, minimally invasive technologies in surgical, diagnostic and skeletal health at the 59th Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists (ACOG) in Washington, DC...

2011-04-20 00:00:28

In honor of Fibroid Awareness Week, Real Women on Health will be discussing all things fibroids this Wednesday with Fibroid Relief Executive Director Tina Krall, Interventional Radiologist Dr. John Fischer, and uterine fibroid patient-turned-advocate Wendy Perkins. Houston, Texas (Vocus/PRWEB) April 18, 2011 On behalf of everyone here at Fibroid Relief, Happy Fibroid Awareness Week! Today kicks off five days dedicated to redoubling our efforts to raise awareness about uterine fibroids and...

2011-04-06 06:35:00

ANDOVER, Mass., April 6, 2011 /PRNewswire/ -- Smith & Nephew's (NYSE: SNN; LSE: SN) Endoscopy Division today announced that its TRUCLEAR(TM) System, an operative hysteroscopy device for the removal of intrauterine polyps and fibroids, has surpassed the 30,000 procedure milestone. The TRUCLEAR System is a first-of-its kind device that pairs the visualization capabilities of a hysteroscope with minimally invasive tissue removal capabilities, allowing a fast and thorough capture and...

2011-03-07 21:38:28

URMC Research Confirms Possible Use of Drug for Painful Fibroids Research continues to show that the controversial abortion drug mifepristone might have another use, as a therapeutic option besides hysterectomy for women who suffer from severe symptoms associated with uterine fibroids. The University of Rochester Medical Center in 2004 began investigating mifepristone, in a class of drugs known as progesterone receptor modulators (PRMs), to treat fibroids, which affect roughly half of all...

2011-03-01 12:55:18

Women who received one of three treatments for uterine fibroids at Brigham and Women's Hospital in Boston said their symptoms diminished and their quality of life significantly increased, according to a new study published in the May issue of Radiology. Uterine fibroids are benign pelvic tumors that occur in as many as one in five women during their childbearing years. Although not all fibroids cause symptoms, some women experience heavy bleeding, pain and infertility. Treatment options...

2011-03-01 08:51:42

(Ivanhoe Newswire) -- Women who received one of three treatments for uterine fibroids at Brigham and Women's Hospital in Boston said their symptoms diminished and their quality of life significantly increased, according to this study. Uterine fibroids are benign pelvic tumors that occur in as many as one in five women during their childbearing years. Although not all fibroids cause symptoms, some women experience heavy bleeding, pain and infertility. Treatment options include hysterectomy,...

2011-01-31 07:30:00

NATICK, Mass., Jan. 31, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved its Renegade® HI-FLO(TM) Fathom® Pre-Loaded System for selective access and delivery of diagnostic, embolic and therapeutic materials into the peripheral vasculature. The system will primarily be used by interventional radiologists for minimally invasive procedures to treat uterine fibroids...

2011-01-07 06:00:00

BEDFORD, Mass., Jan. 7, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today it has acquired Interlace Medical, Inc. (Interlace), the developer and manufacturer of the MyoSure hysteroscopic tissue removal system (MyoSure). Interlace's operations will be integrated within Hologic's GYN...

2010-12-20 09:15:00

BETHESDA, Md., Dec. 20, 2010 /PRNewswire/ -- Women suffering from uterine fibroids, a debilitating condition that affects more than seven million women in the U.S., may soon have reason for hope. Halt Medical, a biomedical company based in the San Francisco Bay Area, is developing a minimally invasive procedure for treating the condition. The company recently presented their findings from studies in Latin America at the NIH Global Fibroid Congress. "Uterine fibroids are the leading...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.